Why Kids’ COVID Vaccines Aren’t Performing Like Adults’

March 29, 2022

(The Atlantic) – An infant-and-toddler COVID vaccine, perhaps even two, could debut by summer’s start, if the FDA and the CDC give their official nods. But those long-awaited shots may not be met with much fanfare. “If this were January, I’d be like, Oh my god, get me whatever,” says Stephanie Langel, an immunologist at Duke University, whose son will turn 2 in July. Now that cases have come down, and Omicron has all but guaranteed that our original-recipe shots won’t deliver the same perks they once did, the decisions are tougher for everyone involved. The other COVID vaccines in our roster easily cleared the thresholds that had been set for success. In this last inoculation stretch, the tiniest doses on the table will push parents and federal regulators to grapple, in ways they haven’t before, with what makes a COVID vaccine good enough. (Read More)